ScreenerHero

SPRINT Sprint Bioscience AB (publ)

STO · SE · Healthcare · Biotechnology · sprintbioscience.com
3.460SEK-3.35%Mkt Cap: 34.92M $P/E: 4.94

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap34.92M USD
Enterprise Value26.71M USD
Revenue (TTM)13.33M USD
Gross Profit14.74M USD
Net Income (TTM)8.77M USD
Revenue/Share1.32 SEK
Last Price3.460 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0006343745
Valuation
P/E (Trailing)4.94
P/E (Forward)2.72
PEG—
EV/EBITDA3.49
EV/Revenue2.00
P/S2.67
P/B4.23
EPS (TTM)0.70
EPS (Forward)1.30
52W Range
0.536072% of range4.590
52W High4.590 SEK
52W Low0.5360 SEK
Profitability
Gross Margin92.18%
Oper. Margin-331720.00%
EBITDA Margin57.40%
Profit Margin54.88%
ROE76.97%
ROA67.13%
Growth
Revenue Growth-100.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF7.99M USD
CapEx (TTM)8.99K USD
FCF Margin30.22%
FCF Yield11.53%
Net Debt-8.92M USD
Net Debt/EBITDA-1.17
Balance Sheet
Debt/Equity—
Current Ratio7.08
Quick Ratio7.08
Book Value/Sh0.83 SEK
Cash/Share0.88 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.100 SEK
Upside (mean)+47.4%
Target Range5.100 SEK – 5.100 SEK
# Analysts1
Ownership
Shares Out.105.52M
Float93.41M
Insiders27.84%
Institutions40.07%
Technical
SMA 503.233 (+7.0%)
SMA 2002.894 (+19.5%)
Beta-0.52
S&P 52W Chg14.58%
Avg Vol (30d)307.28K
Avg Vol (10d)252.36K
Technical Indicators
RSI (14)61.2
MACD0.0850
MACD Signal-0.0044
MACD Hist.+0.0894
BB Upper3.663 SEK
BB Middle3.047 SEK
BB Lower2.432 SEK
BB Width40.39%
ATR (14)0.2129 SEK
Vol Ratio (20d)0.36x